Laboratory Testing for a Patient with BMI 42 kg/m²
For a patient with class 3 obesity (BMI 42 kg/m²), you should order a comprehensive metabolic screening panel including: fasting glucose or HbA1c, complete lipid panel (total cholesterol, HDL-C, LDL-C, triglycerides, non-HDL cholesterol), liver function tests (ALT/AST), and TSH. 1, 2
Core Metabolic Screening
Diabetes and Prediabetes Screening
- Order fasting plasma glucose, HbA1c, or both 3, 1
- With BMI ≥25 kg/m² and obesity, screening for type 2 diabetes and prediabetes is grade A recommendation 3
- Consider 2-hour oral glucose tolerance test (75-g OGTT) if fasting glucose shows impaired fasting glucose (100-125 mg/dL) to better stratify diabetes risk 3, 4
Lipid Panel
- Order complete lipid panel including:
- This is a grade A recommendation for all patients with obesity 1
Liver Function
- Order ALT (alanine transaminase) to screen for nonalcoholic fatty liver disease (NAFLD) 1, 2, 5
- If ALT is elevated, follow with liver ultrasound or other imaging 1
- Consider calculating Fibrosis-4 Index if NAFLD suspected 6
Thyroid Function
- Order TSH 7
- High prevalence of hypothyroidism in obesity makes this essential 7
- European guidelines specifically recommend testing all patients with obesity for thyroid function 7
Additional Screening Based on Clinical Context
Blood Pressure
Metabolic Syndrome Assessment
Metabolic syndrome is diagnosed with ≥3 of the following 6:
- Waist circumference ≥102 cm (men) or ≥88 cm (women)
- Triglycerides ≥150 mg/dL
- HDL-C <40 mg/dL (men) or <50 mg/dL (women)
- Blood pressure ≥130/85 mmHg
- Fasting glucose ≥100 mg/dL
Sex-Specific Considerations
For women:
- Screen for polycystic ovary syndrome (PCOS) if clinically indicated by history and physical exam 1
For men:
- Consider testosterone level if increased waist circumference or symptoms of hypogonadism present 1
- All men with type 2 diabetes should be evaluated for testosterone deficiency 1
Important Clinical Caveats
Timing and Interpretation
- If initial tests are normal, repeat screening at minimum 3-year intervals 3, 4
- For patients with prediabetes (HbA1c 5.7-6.4% or fasting glucose 100-125 mg/dL), consider annual testing 4
Common Pitfalls to Avoid
- Don't rely on BMI alone - it underestimates adiposity and provides inadequate information about individual health 9
- Don't skip waist circumference measurement - it correlates better with morbidity than BMI alone 1, 10
- Waist circumference >102 cm (men) or >88 cm (women) indicates increased cardiometabolic risk 6
When to Order Additional Tests
Order specialized testing only with clinical suspicion 11, 7:
- Cushing syndrome: Only if clinical features present (moon facies, buffalo hump, striae, proximal muscle weakness)
- Growth hormone deficiency: Only with specific clinical indicators
- Genetic/syndromic obesity: Only if early-onset obesity, dysmorphic features, intellectual disability, hyperphagia, or striking family history 11
Screening for Complications
Based on initial results and clinical presentation, consider screening for 1, 6:
- Obstructive sleep apnea: Clinical questionnaires (STOP-BANG), neck circumference measurement
- Cardiovascular disease: Based on risk factors identified
- Depression/anxiety: Clinical assessment as indicated
Evidence Strength
The recommendations for metabolic screening (glucose, lipids, liver function) in patients with class 3 obesity are supported by multiple high-quality guidelines 1, 2 with grade A evidence. The 2016 AACE/ACE guidelines 1 and 2025 AACE consensus statement 2 provide the most comprehensive and recent framework, emphasizing that these tests are essential for risk stratification and treatment planning in patients with severe obesity.